July 21, 2016 — Agfa HealthCare announced it has received Frost & Sullivan’s 2016 North American Product Leadership Award for Digital Radiography (DR). The research group said that Agfa's "complete portfolio of digital, fixed, mobile and retrofit DR systems, as well as impressive radiography advancements, have earned a solid reputation for service excellence and product reliability."
A cornerstone of Agfa's DR value proposition for customers is Multi-Scale Image Contrast Amplification (MUSICA). Agfa's radiation dose is potentially up to 60 percent lower than conventional systems when MUSICA processing is used with cesium bromide (CR) and cesium iodide (DR) detectors. MUSICA processing also enhances image quality and improves workflow. The radiation dose reduction claim has been cleared by the U.S. Food and Drug Administration under the 510(k) pre-market process.
The MUSICA software optimizes and quality-controls images automatically, while competitors' products require operators to manually adjust contrast, density, sharpness and other elements to augment image quality.
At AHRA 2016 in Nashville, Tenn., Agfa will spotlight the wireless, mobile DX-D 100 with FreeView telescopic column. In addition to learning about productivity gains supported by MUSICA, AHRA attendees will be able to discuss how to secure funding for DR even with reduced capital budgets.
"Now in its third generation, MUSICA is the engine that generates the crisp and detailed images produced by all of Agfa HealthCare's radiography equipment," said Frost & Sullivan Consultant Poornima Srinivasan. "The company offers standardized image quality, low-dose imaging, and the best productivity across its imaging enterprise and radiography fleet."
Each year, Frost & Sullivan presents this award to the company that has developed a product with innovative features and functionality, gaining rapid acceptance in the market. The award recognizes the quality of the solution and the customer value enhancements it enables.
For its Product Leadership Award, Frost & Sullivan analysts independently evaluated two key factors, Product Family Attributes and Business Impact, using a customized Decision Support Scorecard. This tool allows their researchers to objectively analyze performance, according to the key benchmarking criteria, and to assign ratings on that basis.
For more information: www.agfahealthcare.com
July 18, 2024 
